- Home
- NCNA vs ZCMD Comparison
NCNA vs ZCMD Comparison
Compare NCNA & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCNA | ZCMD |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 7.9M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NCNA | ZCMD |
|---|---|---|
| Price | $2.09 | $2.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.9K | 6.5K |
| Earning Date | 06-01-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.18 |
| 52 Week High | $10.00 | $2.10 |
Technical Indicators
Market Signals| Indicator | NCNA | ZCMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 68.03 |
| Support Level | $2.07 | $0.56 |
| Resistance Level | $2.27 | N/A |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 64.18 | 97.37 |
Price Performance
Historical ComparisonAbout NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.